310 related articles for article (PubMed ID: 26561554)
41. Definition, diagnosis and treatment strategies for opioid-induced bowel dysfunction-Recommendations of the Nordic Working Group.
Drewes AM; Munkholm P; Simrén M; Breivik H; Kongsgaard UE; Hatlebakk JG; Agreus L; Friedrichsen M; Christrup LL
Scand J Pain; 2016 Apr; 11():111-122. PubMed ID: 28850449
[TBL] [Abstract][Full Text] [Related]
42. A randomized study of lubiprostone for opioid-induced constipation in patients with chronic noncancer pain.
Cryer B; Katz S; Vallejo R; Popescu A; Ueno R
Pain Med; 2014 Nov; 15(11):1825-34. PubMed ID: 24716835
[TBL] [Abstract][Full Text] [Related]
43. A randomized, placebo-controlled phase 3 trial (Study SB-767905/013) of alvimopan for opioid-induced bowel dysfunction in patients with non-cancer pain.
Irving G; Pénzes J; Ramjattan B; Cousins M; Rauck R; Spierings EL; Kleoudis CS; Snidow JW; Pierce A; Wurzelmann J; Mortensen ER
J Pain; 2011 Feb; 12(2):175-84. PubMed ID: 21292168
[TBL] [Abstract][Full Text] [Related]
44. Subcutaneous methylnaltrexone for treatment of acute opioid-induced constipation: phase 2 study in rehabilitation after orthopedic surgery.
Anissian L; Schwartz HW; Vincent K; Vincent HK; Carpenito J; Stambler N; Ramakrishna T
J Hosp Med; 2012 Feb; 7(2):67-72. PubMed ID: 21998076
[TBL] [Abstract][Full Text] [Related]
45. Clinical Overview and Considerations for the Management of Opioid-induced Constipation in Patients With Chronic Noncancer Pain.
Viscusi ER
Clin J Pain; 2019 Feb; 35(2):174-188. PubMed ID: 30289777
[TBL] [Abstract][Full Text] [Related]
46. Impact of constipation on opioid therapy management among long-term opioid users, based on a patient survey.
Gupta S; Patel H; Scopel J; Mody RR
J Opioid Manag; 2015; 11(4):325-38. PubMed ID: 26312960
[TBL] [Abstract][Full Text] [Related]
47. [Opioid-Induced Constipation in Patients with Cancer Pain].
Aruga E
Gan To Kagaku Ryoho; 2021 Nov; 48(11):1311-1315. PubMed ID: 34795117
[TBL] [Abstract][Full Text] [Related]
48. Hot Topics in Primary Care: Management of Opioid-induced Constipation.
Johnson DA; Argoff CE
J Fam Pract; 2015 Dec; 64(12 Suppl):S4-9. PubMed ID: 26845012
[TBL] [Abstract][Full Text] [Related]
49. Naloxegol , a new drug for the treatment of opioid-induced constipation.
Corsetti M; Tack J
Expert Opin Pharmacother; 2015 Feb; 16(3):399-406. PubMed ID: 25496063
[TBL] [Abstract][Full Text] [Related]
50. Relistor approved for opioid-related constipation.
Traynor K
Am J Health Syst Pharm; 2008 Jun; 65(11):996. PubMed ID: 18499867
[No Abstract] [Full Text] [Related]
51. Opioid-induced Constipation: A Review of Health-related Quality of Life, Patient Burden, Practical Clinical Considerations, and the Impact of Peripherally Acting μ-Opioid Receptor Antagonists.
Argoff CE
Clin J Pain; 2020 Sep; 36(9):716-722. PubMed ID: 32554978
[TBL] [Abstract][Full Text] [Related]
52. Evaluating naloxegol for the treatment of opioid-induced constipation.
Daniali M; Nikfar S; Abdollahi M
Expert Opin Pharmacother; 2020 Jun; 21(8):883-891. PubMed ID: 32129103
[TBL] [Abstract][Full Text] [Related]
53. Pharmacological therapies for opioid induced constipation in adults with cancer.
Boland JW; Boland EG
BMJ; 2017 Aug; 358():j3313. PubMed ID: 28768637
[No Abstract] [Full Text] [Related]
54. Opioid-Induced Constipation (OIC) Guideline.
Crockett S; Greer KB; Sultan S
Gastroenterology; 2019 Jan; 156(1):228. PubMed ID: 30389393
[No Abstract] [Full Text] [Related]
55. Opioid-lnduced Constipation (OIC) Clinical Decision Support Tool.
American Gastroenterological Association
Gastroenterology; 2019 Jan; 156(1):227. PubMed ID: 30389392
[No Abstract] [Full Text] [Related]
56. Opioid-Induced Constipation.
Webster LR
Pain Med; 2015 Oct; 16 Suppl 1():S16-21. PubMed ID: 26461071
[TBL] [Abstract][Full Text] [Related]
57. Treating opioid-induced constipation in patients taking other medications: Avoiding CYP450 drug interactions.
Raffa RB; Taylor R; Pergolizzi JV
J Clin Pharm Ther; 2019 Jun; 44(3):361-371. PubMed ID: 30793348
[TBL] [Abstract][Full Text] [Related]
58. Lubiprostone for the treatment of opioid-induced bowel dysfunction.
Wong BS; Camilleri M
Expert Opin Pharmacother; 2011 Apr; 12(6):983-90. PubMed ID: 21385112
[TBL] [Abstract][Full Text] [Related]
59. Emerging treatments in neurogastroenterology: a multidisciplinary working group consensus statement on opioid-induced constipation.
Camilleri M; Drossman DA; Becker G; Webster LR; Davies AN; Mawe GM
Neurogastroenterol Motil; 2014 Oct; 26(10):1386-95. PubMed ID: 25164154
[TBL] [Abstract][Full Text] [Related]
60. Naloxegol: a review of its use in patients with opioid-induced constipation.
Garnock-Jones KP
Drugs; 2015 Mar; 75(4):419-25. PubMed ID: 25666542
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
